跳至主要内容
临床试验/JPRN-UMIN000018140
JPRN-UMIN000018140已完成未知

Effectiveness and safety of bronchial thermoplasty in the treatment with severe persistent bronchial asthma - Effectiveness and safety of bronchial thermoplasty in patients with severe asthma

Department of Respiratory Medicine, National Center for Global Health and Medicine0 个研究点目标入组 30 人开始时间: 2015年6月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

Asthma-related Quality of Life Questionnaire (AQLQ) and Asthma Control Questionnaire (ACQ)-5 scores were improved at both 1 and 12 months after BT. Mean FEV1 was increased at 1 and 12 months. The mean annual number of severe exacerbations requiring systemic corticosteroids decreased from 5.8 to 2.0 at 12 months after BT. No serious adverse event was observed.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Have a pacemaker, internal defibrillator, or other implantable electronic device. 2.Have a known sensitivity to medications required to perform bronchoscopy, including lidocaine, atropine, and benzodiazepines. 3.Have been previously treated with BT 4.Active respiratory infection 5.Asthma exacerbation or changing dose of systemic corticosteroids for asthma (up or down) in the past 14 days 6.Known coagulopathy. As with other bronchoscopic procedures, patients should stop taking anticoagulants, antiplatelet agents, aspirin, and NSAIDS before the procedure with physician guidance

研究者

发起方
Department of Respiratory Medicine, National Center for Global Health and Medicine

相似试验